ES2052942T3 - Regulador biologico extraido de gingko biloba, activo en diversas patologias. - Google Patents

Regulador biologico extraido de gingko biloba, activo en diversas patologias.

Info

Publication number
ES2052942T3
ES2052942T3 ES89401191T ES89401191T ES2052942T3 ES 2052942 T3 ES2052942 T3 ES 2052942T3 ES 89401191 T ES89401191 T ES 89401191T ES 89401191 T ES89401191 T ES 89401191T ES 2052942 T3 ES2052942 T3 ES 2052942T3
Authority
ES
Spain
Prior art keywords
bioparyl
gingko biloba
ribonucleose
active
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89401191T
Other languages
English (en)
Spanish (es)
Inventor
Mirko Beljanski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abraxas Bio Labs SA
Original Assignee
Abraxas Bio Labs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraxas Bio Labs SA filed Critical Abraxas Bio Labs SA
Application granted granted Critical
Publication of ES2052942T3 publication Critical patent/ES2052942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
ES89401191T 1988-07-19 1989-04-26 Regulador biologico extraido de gingko biloba, activo en diversas patologias. Expired - Lifetime ES2052942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8809738A FR2634380B1 (fr) 1988-07-19 1988-07-19 Regulateur biologique, actif dans diverses pathologies

Publications (1)

Publication Number Publication Date
ES2052942T3 true ES2052942T3 (es) 1994-07-16

Family

ID=9368543

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89401191T Expired - Lifetime ES2052942T3 (es) 1988-07-19 1989-04-26 Regulador biologico extraido de gingko biloba, activo en diversas patologias.

Country Status (8)

Country Link
EP (1) EP0352146B1 (US06312121-20011106-C00033.png)
JP (1) JPH0278628A (US06312121-20011106-C00033.png)
CA (1) CA1337177C (US06312121-20011106-C00033.png)
DE (1) DE68903065T2 (US06312121-20011106-C00033.png)
DK (1) DK355089A (US06312121-20011106-C00033.png)
ES (1) ES2052942T3 (US06312121-20011106-C00033.png)
FR (1) FR2634380B1 (US06312121-20011106-C00033.png)
GR (1) GR3006687T3 (US06312121-20011106-C00033.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
DE4030758A1 (de) * 1990-09-28 1992-04-02 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, insbesondere zur intravenoesen injektion oder infusion, verfahren zu seiner herstellung und den extrakt enthaltende ampullenpraeparate
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
FR2754714B1 (fr) * 1996-10-22 1999-01-22 Roc Sa Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba
FR2759371B1 (fr) * 1997-02-07 1999-03-19 Bio Merieux Utilisation d'un polypeptide, pour obtenir une composition pour detecter, prevenir ou traiter une maladie degenerative et/ou auto-immune
US6030621A (en) * 1998-03-19 2000-02-29 De Long; Xie Ginkgo biloba composition, method to prepare the same and uses thereof
KR100417172B1 (ko) * 2000-08-04 2004-02-05 주식회사 안지오랩 은행엽 엑스를 유효성분으로 하는 혈관신생 억제제
WO2002011745A1 (en) * 2000-08-04 2002-02-14 Angiolab, Inc. Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase
FR2911782A1 (fr) * 2007-01-31 2008-08-01 Jacqueline Martin Comment guerir du sida avec mentha pulegium et ginkgo biloba

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117429C3 (de) * 1971-04-08 1982-04-01 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Verfahren zur Herstellung eines Injektions- bzw. Infusionspräparates mit einem Gehalt an einem Wirkstoffgemisch aus den Blättern von Ginkgo biloba
FR2518406A1 (fr) * 1981-12-22 1983-06-24 Prodipharm Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo

Also Published As

Publication number Publication date
EP0352146A1 (fr) 1990-01-24
FR2634380B1 (fr) 1990-10-12
DK355089D0 (da) 1989-07-18
JPH0278628A (ja) 1990-03-19
EP0352146B1 (fr) 1992-09-30
DE68903065D1 (de) 1992-11-05
DE68903065T2 (de) 1993-03-25
DK355089A (da) 1990-01-20
FR2634380A1 (fr) 1990-01-26
GR3006687T3 (US06312121-20011106-C00033.png) 1993-06-30
CA1337177C (en) 1995-10-03

Similar Documents

Publication Publication Date Title
ES2188595T3 (es) Derivados del acido 1-(2-oxo-acetil)-piperidin-2-carboxilico como sensibilizadores de celulas cancerosas resistentes a multiples farmacos.
CY1106798T1 (el) Ανθρωπινα μεσεγχυματικα βλαστοκυτταρα απο περιφερειακο αιμα
ES2052942T3 (es) Regulador biologico extraido de gingko biloba, activo en diversas patologias.
Horwath-Winter et al. Iodide iontophoresis as a treatment for dry eye syndrome
Plasmeijer et al. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance–the impact of immunosuppression on frequency of cSCC
ES2063011T3 (es) Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente.
ATE211392T1 (de) Verwendung des glialen, neurotrophen faktors (gdnf) zur behandlung von gehörstörungen
DE3752112T2 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
PT92821A (pt) Processo para a preparacao composicoes farmaceuticas para o combate de doencas do tipo psoriase, bem como doencas inflamatorias, incorporando azelastina como substancia activa
ES2196027T3 (es) Tratamiento de enfermedades vasculares degenerativas mediante modulacion de la produccion o actividad del oxido nitrico exogeno.
GR3033157T3 (en) Therapeutic agent for skin or corneal disease.
Reisi et al. Effects of treadmill running on short-term pre-synaptic plasticity at dentate gyrus of streptozotocin-induced diabetic rats
EA200100342A1 (ru) Связывающие соединения адгезионной молекулы нервной клетки
ES2162331T3 (es) Utilizacion del factor de crecimiento del tejido nervioso para conservacion, cultivo o tratamiento de la cornea.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
DE69629436D1 (de) Wirkungen auf der endothelauskleidung und behandlung von vasospastischen erkrankungen
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
ES2118726T3 (es) Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
Kalliomäki et al. Axon reflex sweating in rheumatoid arthritis
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
AR044315A1 (es) Agente para prevenir y/o tratar enfermedades acompañadas de alteraciones de tejidos que comprende un polipeptido
Zhao et al. Radiation-induced up-regulation of Mmp2 involves increased mRNA stability, redox modulation, and MAPK activation
BR0309203A (pt) Processo para inibir crescimento de célula usando oligonucleotìdeos
IT7826263A0 (it) Derivati del piranocromone e composizione terapeutica comprendente gli stessi, per il trattamento di malattie allergiche.
Katiyar et al. Pathology of inflammatory‐reparative response in punched wounds of the chicken skin

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 352146

Country of ref document: ES